ClinConnect ClinConnect Logo
Search / Trial NCT05094622

Physical Training in Patients With POTS After Covid-19

Launched by KAROLINSKA INSTITUTET · Oct 25, 2021

Trial Information

Current as of May 27, 2025

Active, not recruiting

Keywords

Physiotherapy Rehabilitation Physical Exercise Quality Of Life Physical Activity

ClinConnect Summary

This clinical trial is studying the effects of physical training on patients who have developed a condition called postural orthostatic tachycardia syndrome (POTS) after having Covid-19. POTS can cause symptoms like dizziness and fatigue when standing up, which can significantly impact daily life. The trial aims to see if a specially designed exercise program can help improve physical activity levels and overall quality of life for these patients.

To be eligible for the study, participants must be adults over 18 years old who have been diagnosed with POTS following Covid-19. During the trial, participants will take part in a 12-week exercise program, attending sessions three times a week. Before and after this program, researchers will measure various factors like physical ability and mental well-being to evaluate the program's effectiveness. Additionally, participants will share their personal experiences through interviews, helping to understand how the training impacts their lives.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria: Adult patients (\>18 years) diagnosed with postural orthostatic tachycardia syndrome after Covid-19.
  • Exclusion Criteria: Patient not able to perform the intervention due to cognitive or physical dysfunction, Already on-going physical intervention.

About Karolinska Institutet

Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.

Locations

Stockholm, , Sweden

Patients applied

0 patients applied

Trial Officials

Malin Nygren Bonnier, PhD

Principal Investigator

Karolinska Institutet

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials